Tests to evaluate liver health
| Blood tests | |
| ALT, AST | Measures hepatocyte damage and liver inflammation |
| APRI | Measures liver fibrosis based on AST/platelet count ratio |
| FIB-4 | Measures liver fibrosis based on (age × AST)/ (platelet × √ALT) |
| Fibrosure (Fibrotest) | Measures 5 markers: a-2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, and GGT; predicts liver fibrosis |
| Hepascore | Measures 4 markers: α-2-macroglobulin, hyaluronic acid, bilirubin, and GGT; predicts liver fibrosis |
| NASH Fibrotest | Measures fibrosis for MASH; can estimate amount of fat in liver |
| Scans | |
| Fibroscan/elastography | Detects noninvasively (by ultrasound or MRI) degree of liver stiffness and can estimate liver fat content |
| Blood tests | |
| ALT, AST | Measures hepatocyte damage and liver inflammation |
| APRI | Measures liver fibrosis based on AST/platelet count ratio |
| FIB-4 | Measures liver fibrosis based on (age × AST)/ (platelet × √ALT) |
| Fibrosure (Fibrotest) | Measures 5 markers: a-2-macroglobulin, haptoglobin, apolipoprotein A1, bilirubin, and GGT; predicts liver fibrosis |
| Hepascore | Measures 4 markers: α-2-macroglobulin, hyaluronic acid, bilirubin, and GGT; predicts liver fibrosis |
| NASH Fibrotest | Measures fibrosis for MASH; can estimate amount of fat in liver |
| Scans | |
| Fibroscan/elastography | Detects noninvasively (by ultrasound or MRI) degree of liver stiffness and can estimate liver fat content |
GGT, γ-glutamyltranspeptidase; MASH, metabolic dysfunction–associated steatohepatitis; MRI, magnetic resonance imaging; ; NASH, nonalcoholic steatohepatitis.